The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mutational analysis of >14,000 NGS tests from community oncology practices: The Sarah Cannon molecular landscape.
 
Howard A. Burris III
Employment - HCA Healthcare
Leadership - HCA Healthcare
Stock and Other Ownership Interests - HCA Healthcare
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Eisai (Inst); FORMA Therapeutics (Inst); Incyte (Inst); Janssen (Inst); MedImmune (Inst); Mersana (Inst); Novartis (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
Research Funding - Agios (Inst); Archer (Inst); Arvinas (Inst); AstraZeneca (Inst); BioAtla (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CicloMed (Inst); CytomX Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Immunocore (Inst); Incyte (Inst); Janssen (Inst); Jiangsu Hengrui Medicine (Inst); Jounce Therapeutics (Inst); Kyocera (Inst); Lilly (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Revolution Medicines (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); TG Therapeutics (Inst); Verastem (Inst); Vertex (Inst)
Expert Testimony - Novartis
 
Daniel Schlauch
No Relationships to Disclose
 
Yasha Sharma
Employment - Convergent Dental (I); Sarah Cannon Research Institute
Stock and Other Ownership Interests - Convergent Dental (I)
 
Shaita Picard
Employment - Sarah Cannon Research Institute
Travel, Accommodations, Expenses - Sarah Cannon Research Institute
 
Connor Higgins
Employment - Genospace, LLC; Sarah Cannon Research Institute
Travel, Accommodations, Expenses - Genospace, LLC; Sarah Cannon Research Institute
Other Relationship - Genospace, LLC; HCA Healthcare; Sarah Cannon Research Institute
 
Amanda Misch
Employment - HCA Healthcare
 
Rebecca Lachs
Employment - Sarah Cannon Research Institute
Stock and Other Ownership Interests - HCA Healthcare
Travel, Accommodations, Expenses - Sarah Cannon Research Institute
 
Niall O'Connor
Employment - IBM (I); IQVIA (I); IQVIA (I); Sarah Cannon Research Institute/Genospace
Leadership - Genospace
Stock and Other Ownership Interests - HCA Healthcare
 
Mick Correll
Employment - Sarah Cannon Research Institute
Stock and Other Ownership Interests - HCA Healthcare; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Patents pending for technologies related to information system for precision medicine
 
David Spigel
Leadership - TriStar Centennial Medical Center
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Evelo Therapeutics (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Precision Oncology (Inst); Takeda (Inst); TRM Oncology (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Pfizer (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Genzyme; Intuitive Surgical; Lilly; Merck; Pfizer; Purdue Pharma; Spectrum Pharmaceuticals; Sysmex
 
Suzanne Fields Jones
Consulting or Advisory Role - Clovis Oncology (Inst); Janssen (Inst); Novartis (Inst); Onyx (Inst); Teva (Inst); Vertex (Inst)
 
Holli Hutcheson Dilks
No Relationships to Disclose
 
Andrew McKenzie
No Relationships to Disclose